A. Nasr

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt

I. Waked, M. Said, G. Esmat, 2018, Alimentary pharmacology & therapeutics.

NS34A resistance-associated substitutions in chronic hepatitis C in Upper Egypt and regression of liver fibrosis after direct-acting antiviral therapy

N. Makhlouf, M. Alboraie, M. Mekky, 2021, Egyptian Liver Journal.

Impact of Two Sofosbuvir Containing Regimens on the Haematological and Biochemical Profile of Egyptian Patients with Hepatitis C related Compensated Cirrhosis

N. Makhlouf, A. Nasr, Nasr K. Khalil, 2019 .

Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)

Ashraf A. Omar, Puja Sakhuja, Massimo Pinzani, 2009, Hepatology international.

Doxazosin down‐regulates sodium‐glucose cotransporter‐2 and exerts a renoprotective effect in rat models of acute renal injury

A. Nasr, Shimaa M. Elshazly, A. Shaheen, 2019, Basic & clinical pharmacology & toxicology.

Spontaneous viral clearance of chronic HCV infection in Upper Egypt: A community-based study with a 10 year follow-up

A. Nasr, M. El-Attar, M. Aly, 2010 .

Renal protective effect of nebivolol in rat models of acute renal injury: role of sodium glucose co-transporter 2

A. Nasr, Shimaa M. Elshazly, A. Shaheen, 2020, Pharmacological Reports.

Non-invasive assessment of liver fibrosis in patients with hepatitis C: Shear wave elastography and colour Doppler velocity profile technique versus liver biopsy.

N. Makhlouf, A. Nasr, S. Hassany, 2017, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.